Inflammatory Depression Had Higher Kynurenine Metabolites
A 2026 biomarker study found kynurenine-pathway activation in inflammatory major depressive disorder (MDD), but not across all depression cases. Compared with non-inflammatory MDD and healthy controls, the inflammatory subgroup had higher pathway metabolites, and omega-3 treatment reduced several of them over 8 weeks.1 Research Highlights Inflammatory depression showed kynurenine activation: people with MDD and high-sensitivity …